1,530
Views
101
CrossRef citations to date
0
Altmetric
Treatment: Naxolone

Evaluation of a Naloxone Distribution and Administration Program in New York City

, , , , , & show all
Pages 858-870 | Published online: 03 Jul 2009

REFERENCES

  • Baca C. T., Grant K. J. Take-home naloxone to reduce heroin death. Addiction 2005; 100: 1823–1831
  • March 26, 2005, Retrieved June 30, 2006, from http://www.mapinc.org/drugnews/v05.n540.a02.html Baltimore Sun
  • Bigg D., Maxwell S. Enabling people to stay alive: an effective opiate overdose prevention program. Paper presented at The Fourth National Harm Reduction Conference, Seattle, WA, 2002
  • Centers for Disease Control and Prevention (CDC). Heroin overdose deaths—- Multnomah County, Oregon, 1993–1999. Morbidity and Mortality Weekly Report 2000a; 49: 633–636
  • Centers for Disease Control and Prevention (CDC). Unintentional opiate overdose deaths – King County, Washington, 1990–1999. Morbidity and Mortality Weekly Report 2000b; 49: 636–640
  • Centers for Disease Control and Prevention (CDC). Unintentional and undetermined poisoning deaths – 11 states, 1990–2001. Morbidity and Mortality Weekly Report 2004; 53: 233–238
  • Chicago Recovery Alliance. Opiate OD prevention/intervention work in Chicago. 2006, Retrieved June 30, 2006, from http://www.anypositivechange.org/OD1202.pdf
  • Davidson P. J., Ochoa K. C., Hahn J. A., Evans J. L., Moss A. R. Witnessing heroin-related overdoses: The experiences of young injectors in San Francisco. Addiction 2002; 97: 1511–1516
  • Dettmer K., Saunders B., Strang J. Take home naloxone and the prevention of deaths from opiate overdose: two pilot schemes. British Medical Journal 2001; 322: 895–896
  • Drug Overdose Prevention and Education (DOPE) Project San Francisco, California. 2006, Retrieved July 20, 2006, from http://www.thedopeproject.org/
  • Galea S., Ahern J., Tardiff K., Leon A., Coffin P. O., Derr K., et al. Racial/ethnic disparities in overdose mortality trends in New York City, 1990–1998. Journal of Urban Health 2003; 80(2)201–211
  • Galea S., Worthington N., Markham Piper T., Nandi V. V., Curtis M., Rosenthal D. Provision of naloxone to injection drug users as an overdose prevention strategy: Early evidence from a pilot study in New York City. Addictive Behavior 2006; 31(5)907–912
  • Lenton S. R., Hargreaves K. M. Should we conduct a trial of distributing naloxone to heroin USers for peer administration to prevent fatal overdose?. Medical Journal of Austrialia 2000; 173: 260–263
  • Los Angeles Times. January 30, 2006, Retrieved June 23, 2006, from http://www.latimes.com/news/opinion/la-ed-overdose30jan30,0,5661520.story?coll=la-home-oped
  • Markham Piper T., Rudenstine S., Stancliff S., Sherman S., Nandi V., Clear A., et al. Overdose prevention for injection drug users: Lessons learned from naloxone training and distribution programs in New York City. Harm Reduction Journal 2007; 4: 3
  • Maxwell S., Bigg D., Stanczykiewicz K., Carlberg-Racich S. Prescribing naloxone to actively injecting heroin users: a program to reduce heroin overdose deaths. Journal of Addictive Diseases 2006; 25(3)89–96
  • Medical and Health Research Association of New York City. Ryan White Comprehensive AIDS Resources Emergency Act Title 1. 2006, Request for Proposals. March 3, 2006
  • New York City Department of Health and Mental Hygiene (NYC DOHMH). Summary of vital statistics 2002: The City of New York. Office of Vital Statistics. New York 2003, Retrieved July 26, 2006, fromhttp://www.nyc.gov/html/doh/downloads/pdf/vs/2002sum.pdf
  • New York State Department of Health: Opioid Overdose Prevention Program Emergency Regulations. 2006, Retrieved November 14, 2006, from http://www.health.state.ny.US/diseases/aids/harm_reduction/opioidprevention/regulations.htms.htm
  • Ochoa K. C., Hahn J. A., Seal K. H., Moss A. R. Overdosing among young injection drug USers in San Francisco. Addictive Behaviors 2001; 26: 453–460
  • San Francisco Department of Public Health, Health Commission Meeting. November 15, 2005, Retrieved June 23, 2006, from http://www.sfdph.org/DirectorsRpts/2005DR/DR11152005.pdf
  • Seal K. H., Kral A. H., Gee L., Moore L. D., Bluthenthal R. N., Lorvick J., et al. Predictors and prevention of nonfatal overdose among street-recruited injection heroin users in the San Francisco Bay Area, 1998–1999. American Journal of Public Health 2001; 91(11)1842–1846
  • Seal K. H., Thawley R., Gee L., Bamburger J., Kral A. H., Ciccarone D., et al. Naloxone distribution and cardiopulmonary resUScitation training for injection drug USers to prevent heroin overdose death: A pilot intervention study. Journal of Urban Health 2005; 82: 303–311
  • Sherman S. G., Cheng Y., Kral A H. Prevalence and correlates of opiate overdose among young injection drug users in Baltimore, Maryland. Manuscript under review
  • Sporer K. A. Acute heroin overdose. Annals of Internal Medicine 1999; 130: 584–590
  • Sporer K. A. Strategies for preventing heroin overdose. British Medical Journal 2003; 326(7386)442–444
  • Stancliff S. Personal communication. July 2006
  • Strang J., Powis B., Best D., Vingoe L., Griffiths P., Taylor C., et al. Preventing opiate overdose fatalities with take-home naloxone: pre-launch study of possible impact and acceptability. Addiction 1999; 94: 199–204
  • Tracy M., Piper T M., Ompad D., Bucciarelli A., Coffin P. O., Vlahov D., et al. Circumstances of witnessed drug overdose in New York City: implications for intervention. Drug and Alcohol Dependence 2005; 79(2)181–190

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.